Ataxin 1 (ATXN1) Mouse Monoclonal Antibody [Clone ID: 2F5]
CAT#: AM06558SU-N
Ataxin 1 (ATXN1) mouse monoclonal antibody, clone 2F5, Ascites
Need it in bulk or conjugated?
Get a free quote
CNY 5,346.00
货期*
5周
规格
Cited in 1 publication. |
Specifications
Product Data | |
Clone Name | 2F5 |
Applications | ELISA, FC, IF, IHC, WB |
Recommend Dilution | ELISA: 1/10000. Western Blot: 1/500 - 1/2000. Immunofluorescence: 1/200 - 1/1000. Flow Cytometry: 1/200 - 1/400. Immunohistochemistry on Paraffin Sections: 1/200 - 1/1000. |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Purified recombinant fragment of Human ATXN1 expressed in E. Coli. |
Specificity | Recognizes Ataxin-1 |
Formulation | State: Ascites State: Ascitic fluid containing 0.03% Sodium Azide. |
Conjugation | Unconjugated |
Storage Condition | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. |
Predicted Protein Size | 87 kDa |
Gene Name | ataxin 1 |
Database Link | |
Background | Defects in ATXN1 are the cause of spinocerebellar ataxia type 1 (SCA1) [MIM:164400]; also known as olivopontocerebellar atrophy I (OPCA I or OPCA1). Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease. |
Synonyms | Ataxin 1, ATXN1, ATX1, SCA1 |
Reference Data |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide
,null,
Molecular Therapy. Nucleic Acids
,PubMed ID 31394429
[ATXN1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...